Corona vaccine offered to young children at increased medical risk

Children aged 5 to 11 years with underlying medical conditions are vaccinated against COVID-19. In doing so, the Cabinet follows the Health Council’s advice dated December 3, 2021. This concerns children with certain diseases such as severe asthma, chronic lung disorders or congenital heart defects. These children have a higher chance of ending up in the hospital due to the corona infection. Immunization with a modified dose of the Pfizer vaccine is expected to begin December 20 at the GGD at the invitation of the pediatrician.

Children generally have mild symptoms when infected with the coronavirus. If they have certain diseases, the absolute risk of hospitalization and admission to the intensive care unit is still low, but higher compared to healthy peers. This is evident from various national and international studies. There are also indications that children with underlying conditions have a higher chance of developing multisystem inflammatory syndrome (MIS-C). This is a specific complication of the coronavirus in which an inflammatory reaction of the organs occurs. Finally, the Health Board states in the advice that children can also develop long-term complaints after contracting Long COVID.

A call from the pediatrician, injections into the GGD. Pediatricians are calling on children aged 5 to 11 who are now recommended for a corona vaccination. The GGD was asked to take care of the injections at the GGD vaccination sites. Vaccinations are expected to start from December 20, when the first 42,000 vaccines will be delivered by Wednesday, December 15, 2021.

(Source Wikipedia – 2021)

Comirnaty is a coronavirus vaccine from BioNTech/Pfizer that protects you from coronavirus disease. It is intended for adults and young adults aged 12 and over and helps the body’s immune system prevent COVID-19. A modified dose of the Pfizer vaccine has been declared safe and appropriate for young children by the European Medicines Agency (EMA)

See also  SK Velddriel: Modern dressage horses and small bottom end

Modified Pfizer Vaccine Dose. The European Medicines Agency (EMA) has declared a modified dose of Pfizer’s vaccine to be safe and appropriate for young children. The Board of Health also evaluates that these vaccines for children ages 5 to 11 work well and are safe enough. The vaccine is expected to protect them from disease as well as adults. This also applies to children with an underlying condition.

effects. The side effects of vaccination against corona in children are mild to moderate, according to the Health Council. As with other age groups, side effects often appear after the second dose. No data are available yet on large-scale follow-up studies in young children. This means that it is not yet possible to make statements about any rare side effects that have been reported in young people (less than 30 years old), such as myocarditis and pericarditis. It is clear that the risk of developing myocarditis and pericarditis in children, but also from MIS-C, for example, is much greater with corona infection than with a side effect of vaccination.

The Board of Health will also issue advice on corona vaccination for children aged 5 to 11 years without high medical risks by mid-December 2021 at the latest. This advice includes a circular vaccination for children who live in isolation because a roommate or family member has a serious immune disorder. Read also: Letter to Parliament deciding to vaccinate children aged 5-11 with increased medical risks (pdf 5 pages)